ReP USP - Resultado da busca

Artigo de periodico
Characterization of LGALS3 (galectin-3) as a player in DNA damage response (2014)
Carvalho, Renato S.; Fernandes, Vanessa C.; Nepomuceno, Thales C.; Rodrigues, Deivid C.; Woods, Nicholas T.; Suarez-Kurtz, Guilherme; Chammas, Roger; Monteiro, Alvaro N.; Carvalho, Marcelo A.
Source: Cancer Biology and Therapy. Unidades: IB, FMRP
Subjects: CULTURA DE CÉLULAS (TENDÊNCIAS), NEOPLASIAS (ETIOLOGIA), DANO AO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Renato S. et al. Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biology and Therapy, v. 15, n. 7, p. 840-850, 2014Tradução . . Disponível em: https://doi.org/10.4161/cbt.28873. Acesso em: 01 nov. 2024.
APA
Carvalho, R. S., Fernandes, V. C., Nepomuceno, T. C., Rodrigues, D. C., Woods, N. T., Suarez-Kurtz, G., et al. (2014). Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biology and Therapy, 15( 7), 840-850. doi:10.4161/cbt.28873
NLM
Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response [Internet]. Cancer Biology and Therapy. 2014 ; 15( 7): 840-850.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4161/cbt.28873
Vancouver
Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response [Internet]. Cancer Biology and Therapy. 2014 ; 15( 7): 840-850.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4161/cbt.28873
Artigo de periodico
PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia (2014)
Oliveira, J. C.; Pezuk, J. A.; Brassesco, Maria Sol; Morales, Andressa Gois; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood Cancer. Unidades: IB, FMRP
Subjects: LEUCEMIA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, J. C. et al. PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia. Pediatric Blood Cancer, v. 61, n. 7, p. 1227\20131231, 2014Tradução . . Disponível em: https://doi.org/10.1002/pbc.24978. Acesso em: 01 nov. 2024.
APA
Oliveira, J. C., Pezuk, J. A., Brassesco, M. S., Morales, A. G., Queiroz, R. G. de P., Scrideli, C. A., & Tone, L. G. (2014). PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia. Pediatric Blood Cancer, 61( 7), 1227\20131231. doi:10.1002/pbc.24978
NLM
Oliveira JC, Pezuk JA, Brassesco MS, Morales AG, Queiroz RG de P, Scrideli CA, Tone LG. PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia [Internet]. Pediatric Blood Cancer. 2014 ; 61( 7): 1227\20131231.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/pbc.24978
Vancouver
Oliveira JC, Pezuk JA, Brassesco MS, Morales AG, Queiroz RG de P, Scrideli CA, Tone LG. PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia [Internet]. Pediatric Blood Cancer. 2014 ; 61( 7): 1227\20131231.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/pbc.24978
Artigo de periodico
BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells (2013)
Morales, Andressa Gois; Pezuk, Julia Alejandra; Brassesco, María Sol; Oliveira, Jaqueline Carvalho de; Queiroz, Rosane Gomes de Paula; Machado, Hélio Rubens; Carlotti Júnior, Carlos Gilberto; Neder, Luciano; Oliveira, Harley Francisco de; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Child's Nervous System. Unidades: IB, FMRP
Subjects: PEDIATRIA, CICLO CELULAR (ANÁLISE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORALES, Andressa Gois et al. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells. Child's Nervous System, v. 29, n. 12, p. 2241-2248, 2013Tradução . . Disponível em: https://doi.org/10.1007/s00381-013-2175-8. Acesso em: 01 nov. 2024.
APA
Morales, A. G., Pezuk, J. A., Brassesco, M. S., Oliveira, J. C. de, Queiroz, R. G. de P., Machado, H. R., et al. (2013). BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells. Child's Nervous System, 29( 12), 2241-2248. doi:10.1007/s00381-013-2175-8
NLM
Morales AG, Pezuk JA, Brassesco MS, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Neder L, Oliveira HF de, Scrideli CA, Tone LG. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells [Internet]. Child's Nervous System. 2013 ; 29( 12): 2241-2248.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00381-013-2175-8
Vancouver
Morales AG, Pezuk JA, Brassesco MS, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Neder L, Oliveira HF de, Scrideli CA, Tone LG. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells [Internet]. Child's Nervous System. 2013 ; 29( 12): 2241-2248.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00381-013-2175-8
Artigo de periodico
In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors (2013)
Brassesco, María Sol; Pezuk, Julia Alejandra; Morales, Andressa Gois; Oliveira, Jaqueline Carvalho de; Roberto, Gabriela Molinari; Silva, Glenda Nicioli da; Oliveira, Harley Francisco de; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Cancer Biology and Therapy. Unidades: IB, FMRP
Subjects: CARCINOMA, NEOPLASIAS DA BEXIGA, ANTINEOPLÁSICOS (ESTUDO IN VITRO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María Sol et al. In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors. Cancer Biology and Therapy, v. 14, n. 7, p. 648-657, 2013Tradução . . Disponível em: https://doi.org/10.4161/cbt.25087. Acesso em: 01 nov. 2024.
APA
Brassesco, M. S., Pezuk, J. A., Morales, A. G., Oliveira, J. C. de, Roberto, G. M., Silva, G. N. da, et al. (2013). In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors. Cancer Biology and Therapy, 14( 7), 648-657. doi:10.4161/cbt.25087
NLM
Brassesco MS, Pezuk JA, Morales AG, Oliveira JC de, Roberto GM, Silva GN da, Oliveira HF de, Scrideli CA, Tone LG. In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors [Internet]. Cancer Biology and Therapy. 2013 ; 14( 7): 648-657.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4161/cbt.25087
Vancouver
Brassesco MS, Pezuk JA, Morales AG, Oliveira JC de, Roberto GM, Silva GN da, Oliveira HF de, Scrideli CA, Tone LG. In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors [Internet]. Cancer Biology and Therapy. 2013 ; 14( 7): 648-657.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4161/cbt.25087
Artigo de periodico
Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells (2013)
Brassesco, M. S.; Roberto, G. M.; Morales, Andressa Gois; Oliveira, J. C.; Delsin, L. E. A.; Pezuk, J. A.; Valera, Elvis Terci; Carlotti Júnior, Carlos Gilberto; Rego, Eduardo Magalhães; Oliveira, Harley Francisco de; Scrideli, Carlos Alberto; Umezawa, Kazuo; Tone, Luiz Gonzaga
Source: Chemotherapy Research and Practice. Unidades: IB, FMRP
Subjects: RADIOLOGIA, CITOTOXINAS, NEUROCIRURGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, M. S. et al. Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells. Chemotherapy Research and Practice, 2013Tradução . . Disponível em: https://doi.org/10.1155/2013/593020. Acesso em: 01 nov. 2024.
APA
Brassesco, M. S., Roberto, G. M., Morales, A. G., Oliveira, J. C., Delsin, L. E. A., Pezuk, J. A., et al. (2013). Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells. Chemotherapy Research and Practice. doi:10.1155/2013/593020
NLM
Brassesco MS, Roberto GM, Morales AG, Oliveira JC, Delsin LEA, Pezuk JA, Valera ET, Carlotti Júnior CG, Rego EM, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells [Internet]. Chemotherapy Research and Practice. 2013 ;[citado 2024 nov. 01 ] Available from: https://doi.org/10.1155/2013/593020
Vancouver
Brassesco MS, Roberto GM, Morales AG, Oliveira JC, Delsin LEA, Pezuk JA, Valera ET, Carlotti Júnior CG, Rego EM, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells [Internet]. Chemotherapy Research and Practice. 2013 ;[citado 2024 nov. 01 ] Available from: https://doi.org/10.1155/2013/593020
Artigo de periodico
Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation (2013)
Pezuk, Julia Alejandra; Brassesco, María Sol; Morales, Andressa Gois; Oliveira, Jaqueline Carvalho de; Oliveira, Harley Francisco de; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Cancer Biotherapy and Radiopharmaceuticals. Unidades: IB, FMRP
Subjects: RADIOTERAPIA, MITOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZUK, Julia Alejandra et al. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation. Cancer Biotherapy and Radiopharmaceuticals, v. 28, n. 7, p. 516-522, 2013Tradução . . Disponível em: https://doi.org/10.1089/cbr.2012.1415. Acesso em: 01 nov. 2024.
APA
Pezuk, J. A., Brassesco, M. S., Morales, A. G., Oliveira, J. C. de, Oliveira, H. F. de, Scrideli, C. A., & Tone, L. G. (2013). Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation. Cancer Biotherapy and Radiopharmaceuticals, 28( 7), 516-522. doi:10.1089/cbr.2012.1415
NLM
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Oliveira HF de, Scrideli CA, Tone LG. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 7): 516-522.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1089/cbr.2012.1415
Vancouver
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Oliveira HF de, Scrideli CA, Tone LG. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 7): 516-522.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1089/cbr.2012.1415
Artigo de periodico
Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells (2013)
Pezuk, Julia Alejandra; Brassesco, Maria Sol; Oliveira, Jaqueline Carvalho de; Morales, Andressa Gois; Montaldi, Ana Paula; Sakamoto-Hojo, Elza Tiemi; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Clinical and Experimental Medicine. Unidades: IB, FFCLRP, FMRP
Subjects: ANTINEOPLÁSICOS (ESTUDO IN VITRO), APOPTOSE, NEOPLASIAS DO COLO UTERINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZUK, Julia Alejandra et al. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells. Clinical and Experimental Medicine, v. 13, n. 1, p. 75-80, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10238-011-0166-1. Acesso em: 01 nov. 2024.
APA
Pezuk, J. A., Brassesco, M. S., Oliveira, J. C. de, Morales, A. G., Montaldi, A. P., Sakamoto-Hojo, E. T., et al. (2013). Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells. Clinical and Experimental Medicine, 13( 1), 75-80. doi:10.1007/s10238-011-0166-1
NLM
Pezuk JA, Brassesco MS, Oliveira JC de, Morales AG, Montaldi AP, Sakamoto-Hojo ET, Scrideli CA, Tone LG. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 1): 75-80.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s10238-011-0166-1
Vancouver
Pezuk JA, Brassesco MS, Oliveira JC de, Morales AG, Montaldi AP, Sakamoto-Hojo ET, Scrideli CA, Tone LG. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 1): 75-80.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s10238-011-0166-1
Artigo de periodico
Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma (2013)
Pezuk, J. A.; Brassesco, M. S.; Morales, Andressa Gois; Oliveira, J. C. de; Queiroz, Rosane Gomes de Paula; Machado, Hélio Rubens; Carlotti Júnior, Carlos Gilberto; Serafini, Luciano Neder; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Cancer Gene Therapy. Unidades: IB, FMRP
Subjects: ASTROCITOMA, PROTEÍNAS QUINASES, CICLO CELULAR, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZUK, J. A. et al. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma. Cancer Gene Therapy, v. 20, n. 9, p. 499-506, 2013Tradução . . Disponível em: https://doi.org/10.1038/cgt.2013.46. Acesso em: 01 nov. 2024.
APA
Pezuk, J. A., Brassesco, M. S., Morales, A. G., Oliveira, J. C. de, Queiroz, R. G. de P., Machado, H. R., et al. (2013). Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma. Cancer Gene Therapy, 20( 9), 499-506. doi:10.1038/cgt.2013.46
NLM
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Serafini LN, Scrideli CA, Tone LG. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma [Internet]. Cancer Gene Therapy. 2013 ; 20( 9): 499-506.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/cgt.2013.46
Vancouver
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Serafini LN, Scrideli CA, Tone LG. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma [Internet]. Cancer Gene Therapy. 2013 ; 20( 9): 499-506.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/cgt.2013.46
Artigo de periodico
Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells (2012)
Brassesco, María S.; Pezuk, Julia Alejandra; Morales, Andressa Gois; Oliveira, Jaqueline Carvalho de; Valera, Elvis Terci; Silva, Glenda Nicioli da; Oliveira, Harley Francisco de; Scrideli, Carlos Alberto; Umezawa, Kazuo; Tone, Luiz Gonzaga
Source: Asian Pacific Journal of Cancer Prevention. Unidades: IB, FMRP
Subjects: NEOPLASIAS DA BEXIGA (QUIMIOTERAPIA), APOPTOSE, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María S. et al. Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells. Asian Pacific Journal of Cancer Prevention, v. 13, n. 5, p. 1957-1962, 2012Tradução . . Disponível em: https://doi.org/10.7314/APJCP.2012.13.5.1957. Acesso em: 01 nov. 2024.
APA
Brassesco, M. S., Pezuk, J. A., Morales, A. G., Oliveira, J. C. de, Valera, E. T., Silva, G. N. da, et al. (2012). Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells. Asian Pacific Journal of Cancer Prevention, 13( 5), 1957-1962. doi:10.7314/APJCP.2012.13.5.1957
NLM
Brassesco MS, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Silva GN da, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells [Internet]. Asian Pacific Journal of Cancer Prevention. 2012 ; 13( 5): 1957-1962.[citado 2024 nov. 01 ] Available from: https://doi.org/10.7314/APJCP.2012.13.5.1957
Vancouver
Brassesco MS, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Silva GN da, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells [Internet]. Asian Pacific Journal of Cancer Prevention. 2012 ; 13( 5): 1957-1962.[citado 2024 nov. 01 ] Available from: https://doi.org/10.7314/APJCP.2012.13.5.1957
Trabalho de evento-resumo periodico
Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia (2011)
Oliveira, Jaqueline; Annichini, Maria Sol; Scrideli, Carlos Alberto; Queiroz, Rosane de Paula; Morales, Andressa Gois; Pezuk, Julia; Bomfim, Renata; Yunes, José; Brandalise, Silvia; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidades: FMRP, IB
Subjects: CRIANÇAS, LEUCEMIA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jaqueline et al. Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2011
APA
Oliveira, J., Annichini, M. S., Scrideli, C. A., Queiroz, R. de P., Morales, A. G., Pezuk, J., et al. (2011). Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Oliveira J, Annichini MS, Scrideli CA, Queiroz R de P, Morales AG, Pezuk J, Bomfim R, Yunes J, Brandalise S, Tone LG. Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2011 ; 57( 5): 761.[citado 2024 nov. 01 ]
Vancouver
Oliveira J, Annichini MS, Scrideli CA, Queiroz R de P, Morales AG, Pezuk J, Bomfim R, Yunes J, Brandalise S, Tone LG. Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2011 ; 57( 5): 761.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line (2011)
Morales, Andressa Gois; Pezuk, Julia Alexandre; Oliveira, Jaqueline Carvalho; Suazo, Veridiana Kill; Queiroz, Rosane Gomes de Paula; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidades: FMRP, IB
Subjects: NEOPLASIAS CEREBRAIS, RADIOTERAPIA, QUIMIOTERAPIA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORALES, Andressa Gois et al. Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2011
APA
Morales, A. G., Pezuk, J. A., Oliveira, J. C., Suazo, V. K., Queiroz, R. G. de P., Brassesco, M. S., et al. (2011). Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Morales AG, Pezuk JA, Oliveira JC, Suazo VK, Queiroz RG de P, Brassesco MS, Scrideli CA, Tone LG. Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line. Pediatric Blood & Cancer. 2011 ; 57( 5): 807-808.[citado 2024 nov. 01 ]
Vancouver
Morales AG, Pezuk JA, Oliveira JC, Suazo VK, Queiroz RG de P, Brassesco MS, Scrideli CA, Tone LG. Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line. Pediatric Blood & Cancer. 2011 ; 57( 5): 807-808.[citado 2024 nov. 01 ]
Artigo de periodico
MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells (2011)
Oliveira, Jaqueline Carvalho de; Brassesco, Maria Sol; Morales, Andressa Gois; Pezuk, Julia Alejandra; Fedatto, Paola Fernanda; Silva, Glenda Nicioli da; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Asian Pacific Journal of Cancer Prevention. Unidades: IB, FMRP
Subjects: CARCINOMA (TRATAMENTO), NEOPLASIAS DA BEXIGA, CÉLULAS CULTIVADAS (TÉCNICAS IN VITRO), EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jaqueline Carvalho de et al. MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells. Asian Pacific Journal of Cancer Prevention, v. 12, n. 11, p. 3001-3004, 2011Tradução . . Acesso em: 01 nov. 2024.
APA
Oliveira, J. C. de, Brassesco, M. S., Morales, A. G., Pezuk, J. A., Fedatto, P. F., Silva, G. N. da, et al. (2011). MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells. Asian Pacific Journal of Cancer Prevention, 12( 11), 3001-3004.
NLM
Oliveira JC de, Brassesco MS, Morales AG, Pezuk JA, Fedatto PF, Silva GN da, Scrideli CA, Tone LG. MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells. Asian Pacific Journal of Cancer Prevention. 2011 ; 12( 11): 3001-3004.[citado 2024 nov. 01 ]
Vancouver
Oliveira JC de, Brassesco MS, Morales AG, Pezuk JA, Fedatto PF, Silva GN da, Scrideli CA, Tone LG. MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells. Asian Pacific Journal of Cancer Prevention. 2011 ; 12( 11): 3001-3004.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
Effects of polo-like kinase 1 inhibition on glioblastoma cell lines (2011)
Pezuk, Julia Alejandra; Morales, Andressa Gois; Oliveira, Jaqueline Carvalho; Montaldi, Ana Paula de Lima; Brassesco, Maria Sol Anichini; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidades: FMRP, IB
Subjects: EXPRESSÃO GÊNICA, LINHAGEM CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZUK, Julia Alejandra et al. Effects of polo-like kinase 1 inhibition on glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2011
APA
Pezuk, J. A., Morales, A. G., Oliveira, J. C., Montaldi, A. P. de L., Brassesco, M. S. A., Queiroz, R. G. de P., et al. (2011). Effects of polo-like kinase 1 inhibition on glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Pezuk JA, Morales AG, Oliveira JC, Montaldi AP de L, Brassesco MSA, Queiroz RG de P, Scrideli CA, Tone LG. Effects of polo-like kinase 1 inhibition on glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 808.[citado 2024 nov. 01 ]
Vancouver
Pezuk JA, Morales AG, Oliveira JC, Montaldi AP de L, Brassesco MSA, Queiroz RG de P, Scrideli CA, Tone LG. Effects of polo-like kinase 1 inhibition on glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 808.[citado 2024 nov. 01 ]
Artigo de periodico
BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity (2011)
Morales, Andressa Gois; Brassesco, Maria Sol; Pezuk, Julia Alejandra; Oliveira, Jaqueline Carvalho de; Montaldi, Ana Paula; Hojo, Elza Tiemi Sakamoto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Anti-Cancer Drugs. Unidades: IB, FFCLRP, FMRP
Subjects: OSTEOSSARCOMA (TRATAMENTO), FÁRMACOS, MITOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORALES, Andressa Gois et al. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, v. 22, n. 10, p. 995-1001, 2011Tradução . . Disponível em: https://doi.org/10.1097/cad.0b013e32834a16d4. Acesso em: 01 nov. 2024.
APA
Morales, A. G., Brassesco, M. S., Pezuk, J. A., Oliveira, J. C. de, Montaldi, A. P., Hojo, E. T. S., et al. (2011). BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, 22( 10), 995-1001. doi:10.1097/cad.0b013e32834a16d4
NLM
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4
Vancouver
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4
Trabalho de evento-resumo periodico
Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines (2011)
Brassesco, Maria; Pezuk, Julia Alejandra; Morales, Andressa Gois; Oliveira, Jaqueline Carvalho de; Valera, Elvis Terci; Rego, Eduardo Magalhães; Carlotti Júnior, Carlos Gilberto; Umezawa, Kazuo; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidades: FMRP, IB
Subjects: APOPTOSE, CRIANÇAS, NEOPLASIAS CEREBRAIS (TRATAMENTO), FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria et al. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2011
APA
Brassesco, M., Pezuk, J. A., Morales, A. G., Oliveira, J. C. de, Valera, E. T., Rego, E. M., et al. (2011). Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Brassesco M, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Rego EM, Carlotti Júnior CG, Umezawa K, Scrideli CA, Tone LG. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 803-804.[citado 2024 nov. 01 ]
Vancouver
Brassesco M, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Rego EM, Carlotti Júnior CG, Umezawa K, Scrideli CA, Tone LG. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 803-804.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
Could EMP3, CA12, CKS2 and PDPN be potential targets genes in astrocytic tumors? (2010)
Scrideli, Carlos Alberto; Queiróz, Rosane de Paula; Carlotti Jr., Carlos Gilberto; Machado, Hélio Rubens; Okamoto, Oswaldo Keith ; Silveira, Vanessa Silva; Cortez, Maria Angelica Abdala; Neder, Luciano; Valera, Elvis Terci; Oba-Shinjo, Sueli Mieko; Marie, Suely Kizue Nagahashi; Tone, Luiz Gonzaga
Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Societyof Paediatric Oncology (SIOP). Unidades: FM, FMRP, IB
Subjects: ASTRÓCITOS (PATOLOGIA), GENES (ANÁLISE), NEOPLASIAS CEREBRAIS, PROGNÓSTICO, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto et al. Could EMP3, CA12, CKS2 and PDPN be potential targets genes in astrocytic tumors?. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pbc.22779/pdf. Acesso em: 01 nov. 2024. , 2010
APA
Scrideli, C. A., Queiróz, R. de P., Carlotti Jr., C. G., Machado, H. R., Okamoto, O. K., Silveira, V. S., et al. (2010). Could EMP3, CA12, CKS2 and PDPN be potential targets genes in astrocytic tumors? Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/pbc.22779/pdf
NLM
Scrideli CA, Queiróz R de P, Carlotti Jr. CG, Machado HR, Okamoto OK, Silveira VS, Cortez MAA, Neder L, Valera ET, Oba-Shinjo SM, Marie SKN, Tone LG. Could EMP3, CA12, CKS2 and PDPN be potential targets genes in astrocytic tumors? [Internet]. Pediatric Blood and Cancer. 2010 ; 55( 5): 917.[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.22779/pdf
Vancouver
Scrideli CA, Queiróz R de P, Carlotti Jr. CG, Machado HR, Okamoto OK, Silveira VS, Cortez MAA, Neder L, Valera ET, Oba-Shinjo SM, Marie SKN, Tone LG. Could EMP3, CA12, CKS2 and PDPN be potential targets genes in astrocytic tumors? [Internet]. Pediatric Blood and Cancer. 2010 ; 55( 5): 917.[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.22779/pdf

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Indexado em